<h6>Objective :</h6><p><a href="https://www.delveinsight.com/consulting/pipeline-assessment-services" rel="noopener noreferrer" target="_blank"><strong><u>Assessment of pipeline</u></strong></a> activities around client’s area of interest to support strategic decisions</p><h6>Problem Statement:</h6><p>A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.</p><h6>Our Methodology:</h6><ul><li>Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products</li><li>Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena</li><li>Company Assessment via Funding/Collaboration/Partnership Analysis</li><li>Analyst Comments on <a href="https://www.delveinsight.com/consulting/r-and-d-analysis" rel="noopener noreferrer" target="_blank"><strong><u>R&amp;D developments</u></strong></a></li></ul><h6>Results:</h6><ul><li>Detailed pipeline profiles of T-Cell Receptor (TCR) products</li><li>Additional comments on Inactive (Discontinued and Dormant) products.</li><li>Therapeutic assessment of active pipeline products</li><li>Detailed profiles of Companies with key coverage of collaboration/<a href="https://www.delveinsight.com/consulting/partner-identification-services" rel="noopener noreferrer" target="_blank"><strong><u>partnering activities</u></strong></a></li></ul>

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment. 

Pipeline Assessment

Delveinsight Business Research provides smart Pipeline Assessment services to address your business challenges.